4
Changes in Ownership
Acrivon Therapeutics, Inc. Filed Acc 0000905148-26-003499
Chief Financial Officer sold 1,142 shares at $1.57 ($1,793)
From the SEC's structured data for this filing
Trades in this filing
Levy Adam D. · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-08-04 | Sale : show line 1 in the form | −1,142 | $1.57 | $1,793 | 66,008 | D |
| Open-market sales · 1,142 sh · avg $1.57 · $1,793 | ||||||
Loading xslF345X06/form4.xml…